Page 134 - CW E-Magazine (5-8-2025)

Top Stories

applications, offering students a com- nent, aimed at accelerating the adop- seminars, and local collaborations
prehensive framework on sustainabi- tion of sustainable manufacturing prac- designed to implement and promote eco-
lity. Topics include waste management, tices. This includes the development friendly technologies at the grassroots
greenhouse gas emission measurement of life cycle assessment tools, carbon level. To further strengthen the indus-
and ESG compliance. By incorporating footprint analysis methodologies, and try-academia bridge, the collaboration
theoretical concepts alongside indus- policy advocacy to support the crea- will focus on securing CSR funding,
try case studies, the course is designed tion of environmentally responsible inviting industry leaders for guest lec-
to equip students with the technical regulations. Scientifi c insights genera- tures, launching student training pro-
and decision-making skills needed to ted through the partnership will guide grams, and modernising laboratory in-
lead sustainable transformation across decision-making and promote public frastructure. These steps are expected
sectors. awareness. to drive industry-funded research pro-
jects and foster real-world applications
The partnership also includes a Community outreach forms a vital of academic research in sustainable
strong industry collaboration compo- part of this initiative, with workshops, industrial practices.
TRANSLATIONAL RESEARCH
ICT and ITRI sign agreement for biopharma focussed

research & manufacturing

The Institute of Chemical Techno- stage discovery and scalable clinical  Shared platforms for analytical

logy (ICT), Mumbai and the India’s and commercial translation. sciences, formulation, and quality
Translational Research Initiative (ITRI) systems; and
have signed a formal Expression of This initiative, along with the  Advanced training and upskilling

Interest (EOI) to jointly catalyse the con- catalytic support of ITRI, seeks to zones for India’s biopharma work-
struction of the Mumbai Biocluster – a deliver a multiplier effect on national force.
cutting-edge, eight-storey facility dedi- R&D output by accelerating inno-
cated to advancing translational bio- vations to the clinic and market The Mumbai Biocluster will offer
pharmaceutical research, training, and through: high-end shared instrumentation to
manufacturing in India.  A GMP-ready biologics pilot reduce capital burden using service
plant; driven business model; accelerated
The Mumbai Biocluster is a res-  Dedicated centres for rare diseases, technology validation and scale-up infra-
ponse to one of the most critical chal- process development, synthetic bio- structure; cross-disciplinary colla-
lenges in Indian innovation – bridging logy, and AI-powered drug deve- boration platforms between depart-
the “valley of death” between early- lopment; ments and institutions; and workforce
development programmes and entre-
preneurship pathways for students and
researchers.

The India Translational Research
Institute (ITRI) is a philanthropic ini-
tiative that catalyses funding for ambi-
tious research projects by collaborating
with philanthropists and donors. By
setting up translational research centres
(TRCs) at premier research institutions,
ITRI aims to catalyse the lab-to-mar-
ket journey of academic innovations
through partnerships between aca-
demia, industry, and mission-driven
funders.

134 Chemical Weekly August 5, 2025

Contents Index to Advertisers Index to Products Advertised